2024
DOI: 10.3390/jpm14010061
|View full text |Cite
|
Sign up to set email alerts
|

Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice

Hassam Ali,
Muhammad Shahzil,
Vishali Moond
et al.

Abstract: This review provides a practical and comprehensive overview of non-pharmacological interventions for metabolic-associated fatty liver disease (MASLD), focusing on dietary and exercise strategies. It highlights the effectiveness of coffee consumption, intermittent fasting, and Mediterranean and ketogenic diets in improving metabolic and liver health. The review emphasizes the importance of combining aerobic and resistance training as a critical approach to reducing liver fat and increasing insulin sensitivity. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 147 publications
0
2
0
Order By: Relevance
“…Furthermore, the recommendation of complete abstinence from alcohol may leave a grey area for patients who consume alcohol in moderation and may suffer from both alcoholic and metabolic diseases. However, some individuals perceive the term ‘steatosis’ to have a negative connotation [ 5 , 6 ], so the three large associations dealing with liver diseases led to a Delphi process to create a new nomenclature. The chosen name to replace NAFLD is MASLD—metabolic dysfunction-associated steatotic liver disease [ 7 , 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, the recommendation of complete abstinence from alcohol may leave a grey area for patients who consume alcohol in moderation and may suffer from both alcoholic and metabolic diseases. However, some individuals perceive the term ‘steatosis’ to have a negative connotation [ 5 , 6 ], so the three large associations dealing with liver diseases led to a Delphi process to create a new nomenclature. The chosen name to replace NAFLD is MASLD—metabolic dysfunction-associated steatotic liver disease [ 7 , 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…MetALD, although less well-defined in the literature, is increasingly implicating a requirement for the specific management of the disease and future prospective studies for better defining its natural history [5]. As understanding of MASLD and MetALD evolves, there is a growing emphasis on identifying modifiable lifestyle factors, such as diet and physical activity, that can mitigate the diseases progression [6].…”
Section: Introductionmentioning
confidence: 99%